Search

everythinglearnresearchcommunity

for

Search:↓

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Researchers found a new ABCD1 gene mutation linked to a rare brain and nerve disorder with unusual brain changes.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

No treatment fully prevents hair loss from chemotherapy yet.

Cosmetic surgery is more popular and cost-effective, but outcomes depend on the surgeon's skill and all procedures have potential complications.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Calcium is important for stem cell function and maintenance, especially in blood and skin cells.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Follicle Stimulating Hormone is important for fertility.

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

CDP is crucial for lung and hair follicle cell development.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Taking too many vitamin and mineral supplements can cause serious health problems.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.